A natural killer–dendritic cell axis defines checkpoint therapy–responsive tumor microenvironmentsKevin C. Barry, Matthew F. Krummel, Joy Hsu et al.|Nature Medicine|2018Cited by 1k
Unleashing Type-2 Dendritic Cells to Drive Protective Antitumor CD4+ T Cell ImmunityMikhail Binnewies, Matthew F. Krummel, Adriana M. Mujal et al.|Cell|2019Cited by 617
Detection of somatic mutations and HPV in the saliva and plasma of patients with head and neck squamous cell carcinomasYuxuan Wang, Nishant Agrawal, Joseph A. Califano et al.|Science Translational Medicine|2015Cited by 502
Dynamic CD8+ T cell responses to cancer immunotherapy in human regional lymph nodes are disrupted in metastatic lymph nodesMaha K. Rahim, Matthew H. Spitzer, Trine Line Hauge Okholm et al.|Cell|2023Cited by 410
Management of Salivary Gland Malignancy: ASCO GuidelineJ.L. Geiger, Patrick K. Ha, Nofisat Ismaila et al.|Journal of Clinical Oncology|2021Cited by 401